1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine has been researched along with cgs 24012 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobson, KA; van Galen, PJ; Williams, M | 1 |
| Jarrott, B; Krstew, E; Lawrence, AJ | 1 |
1 review(s) available for 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine and cgs 24012
| Article | Year |
|---|---|
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
Topics: Adenosine; Animals; Humans; Models, Chemical; Receptors, Purinergic; Second Messenger Systems; Structure-Activity Relationship | 1992 |
1 other study(ies) available for 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine and cgs 24012
| Article | Year |
|---|---|
Complex interactions between nitric oxide and adenosine receptors in the rat isolated nodose ganglion.
Topics: Adenosine; Animals; Antineoplastic Agents; Diethylamines; Dose-Response Relationship, Drug; Drug Interactions; Electrophysiology; In Vitro Techniques; Male; Neurons, Afferent; Nitric Oxide; Nodose Ganglion; Norbornanes; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Vagus Nerve; Xanthines | 1997 |